Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
70%
Chronic Graft-versus-host Disease (cGVHD)
69%
Tumor
68%
T Cells
63%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
56%
Natural Killer Cells
54%
Smokers
53%
Hematopoietic Cell Transplantation
47%
United States
46%
Minnesota
45%
Transplantation
39%
Graft-versus-host Disease (GvHD)
37%
Acute Myeloid Leukemia
37%
Tobacco
36%
Odds Ratio
36%
Hazard Ratio
36%
Older Adults
34%
Clinical Trials
34%
Risk Factors
33%
Breast Cancer
32%
Nicotine
31%
Gene Expression
31%
DNA Adducts
31%
Overall Survival
30%
Obesity
30%
In Cancer
30%
Atherosclerotic Risk Factors
29%
Children's Oncology Group
29%
COVID-19
28%
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
28%
High Risk
27%
Carcinogen
27%
Prostate Cancer
26%
Chemotherapy
25%
Cigarette
25%
Metabolism
25%
Lung
23%
Confidence Interval
23%
Survivors
22%
African American
22%
Smoking Cessation
22%
Liver
22%
Inflammation
21%
Spinocerebellar Ataxia
21%
Mouse Model
21%
Body Mass Index
21%
Lung Cancer
21%
Apoptosis
21%
Meta-analysis
20%
Leukemia
20%
Hematopoietic Stem Cell Transplantation
20%
Umbilical Cord Blood
20%
Bone Marrow Transplantation
20%
Cigarette Smoking
20%
Childhood Cancer Survivors
19%
Cancer Cells
19%
Acute Lymphoblastic Leukemia
19%
Bone Marrow
19%
Randomized Controlled Trial
19%
Colorectal Cancer
19%
Regulatory T Cells
18%
Pediatric
18%
Quality of Life
18%
B Cells
17%
Single nucleotide Polymorphism
17%
Insulin-like
17%
MicroRNA
17%
Unrelated Donor
17%
Diabetes
17%
Cardiovascular Disease
17%
Photosystem II
17%
Cardiac Magnetic Resonance Imaging (cMRI)
17%
Physical Activity
17%
Transcription Factor
17%
CD4+ T
16%
Cotinine
16%
Genotype
16%
Growth Factors
16%
Umbilical Cord Blood Transplantation
16%
Childhood Cancer Survivor Study
16%
Clinical Outcomes
16%
Placebo
16%
Immune Response
16%
Treg
15%
Tumor Cells
15%
Marrow Transplant
15%
Sleeping Beauty Transposon
15%
Cardiovascular Risk Factors
15%
Reduced-intensity Conditioning
15%
Induced Pluripotent Stem Cells (iPSCs)
14%
Cigarette Smokers
14%
Ovarian Cancer
14%
Pediatric Patients
14%
Overexpression
14%
Gene Therapy
14%
Genome-wide Association Study
14%
Phosphorylation
14%
Dendritic Cells
14%
Cell Proliferation
14%
Hematopoietic Stem Cell Transplant
14%
Medicine and Dentistry
Diseases
100%
Malignant Neoplasm
84%
Neoplasm
58%
Hematopoietic Cell
56%
Breast Cancer
45%
Cell Transplantation
44%
Pediatrics
44%
Childhood Cancer
40%
Oncology
37%
Genetics
36%
Chemotherapy
36%
Cancer
36%
Overall Survival
36%
Tumor
35%
Adolescence
34%
Hazard Ratio
30%
Clinical Trial
30%
Odds Ratio
29%
Biological Marker
28%
Atherosclerosis
28%
Acute Myeloid Leukemia
28%
Lung
25%
Prostate Cancer
25%
Infection
24%
Quality of Life
24%
Magnetic Resonance Imaging
24%
Body Mass Index
24%
Health Care Cost
23%
Diabetes
22%
Radiation Therapy
22%
Prevalence
22%
Cardiovascular Disease
22%
COVID-19
21%
Hematopoietic Stem Cell Transplantation
20%
Acute Lymphoblastic Leukemia
20%
Leukemia
20%
Recurrent Disease
20%
In Vitro
20%
Cardiovascular System
19%
Cancer Cell
19%
Oral
19%
Morbidity
19%
Systematic Review
18%
Cancer Therapy
17%
Nicotine
17%
Education
16%
T Cell
16%
Colorectal Carcinoma
15%
Ovarian Cancer
15%
Gene Expression
15%
Cord Blood
15%
Randomized Controlled Trial
15%
Adverse Event
15%
Urinary System
15%
Bone Marrow Transplantation
14%
Surgeon
14%
Inflammation
14%
Placebo
14%
Nicotine Withdrawal
14%
Metastatic Carcinoma
14%
Stem Cell
14%
Cohort Analysis
13%
Human Immunodeficiency Virus
13%
Logistic Regression Analysis
13%
Biopsy Technique
13%
Lung Cancer
13%
Metabolite
13%
Non Small Cell Lung Cancer
13%
Myelodysplastic Syndrome
12%
Sickle-Cell Disease
12%
Progression Free Survival
12%
Melanoma
12%
Cohort Effect
12%
Clinician
12%
Pediatrics Patient
12%
Graft Versus Host Reaction
12%
Allograft
12%
Chronic Graft Versus Host Disease
12%
Physical Activity
11%
Cell Therapy
11%
Maturity Onset Diabetes of the Young
11%
Wart Virus
11%
Congestive Heart Failure
11%
Comorbidity
11%
Lifespan
11%
Etiology
11%
Arm
11%
Carcinogenesis
11%
Reduced Intensity Conditioning
10%
Meta-Analysis
10%
Cross Sectional Study
10%
Receptor
10%
Infusion
10%
Carcinogen
10%
Hodgkin's Lymphoma
9%
Computer Assisted Tomography
9%
Tobacco Use
9%
Cardiovascular Risk
9%
Medicare
9%
Platelet
9%